Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis
NCT04208646 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2023-08-01
Summary
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy
Conditions
Interventions
- BIOLOGICAL
-
Mesenchymal progenitor cells
Allogenic Adipose tissue-derived mesenchymal progentior cells administrated for intra- articular use
- BIOLOGICAL
-
No mesenchymal progenitor cells
No mesenchymal progenitor cells for intra- articular use
Sponsors & Collaborators
-
RenJi Hospital
collaborator OTHER -
Shanghai 6th People's Hospital
collaborator OTHER -
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
collaborator OTHER -
Second Affiliated Hospital, School of Medicine, Zhejiang University
collaborator OTHER -
China-Japan Friendship Hospital
collaborator OTHER -
Huashan Hospital
collaborator OTHER -
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
collaborator OTHER -
Shanghai AbelZeta Ltd.
lead INDUSTRY
Principal Investigators
-
Chunde Bao · RenJi Hospital
-
Changqing Zhang · Shanghai 6th People's Hospital
-
Guochun Wang · China-Japan Friendship Hospital
-
Chengqing Yi · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
-
Shigui Yan · Second Affiliated Hospital, School of Medicine, Zhejiang University
-
Weiguo Wan · Huashan Hospital
-
Jinwu Wang · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-16
- Primary Completion
- 2021-06-30
- Completion
- 2023-07-31
Countries
- China
Study Locations
More Related Trials
-
Autologous Adipose Stem Cells and Platelet Rich Plasma Therapy for Patients With Knee Osteoarthritis
NCT02142842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.
NCT07106229 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects
NCT02855073 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells
NCT04212728 ·Status: UNKNOWN ·Phase: NA
-
Intra-articular Injection of MSCs in Treatment of Knee OA
NCT03028428 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells
NCT01586312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis
NCT03589287 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis
NCT02784964 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis
NCT03788265 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis
NCT02658344 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
NCT04448106 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy
NCT05933434 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Allogeneic Mesenchymal Stem Cells for Osteoarthritis
NCT01448434 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis
NCT02838069 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
NCT04427930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells
NCT02123368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Knee Osteoarthritis (KOA) by Injection of Autologous Adipose-derived Vascular Matrix Components (SVF) Into Joint Cavity
NCT06109220 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
NCT06084988 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
NCT03990805 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis
NCT03602872 ·Status: WITHDRAWN ·Phase: PHASE1
-
Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis
NCT02805855 ·Status: COMPLETED ·Phase: PHASE1
-
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
NCT04821102 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis
NCT04130100 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.
NCT05086939 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis
NCT06082440 ·Status: RECRUITING ·Phase: EARLY_PHASE1